Franchise News
Bank of America to Stop Supplying Dollar Bills to Angola, Residents are Encouraged to Use Euros, or Other Currencies Instead
NextEra to Sell Fossil Generating Assets in Texas for $1.59 Billion, Reduce Exposure in the Power Business
Merck Weighing Sale of Allergy Business, Looks to Reduce Debt
Merck KGaA, a German drugs and chemicals maker, is considering the sale of its allergy business Allergopharma, people with knowledge of the matter told Bloomberg. The German company is looking to reduce its debt following the $17 billion acquisition of Sigma-Aldrich Corp.
Latest News
Durable Goods Orders in the U.S. Rise 3 Percent in October
New orders for manufactured durable goods in the U.S. have increased a seasonally adjusted three percent in October, following two consecutive months of decreases, according to a news release issued by the U.S. Census Bureau.
Disney's Cable Channels Losing Millions of Subscribers, with ESPN Losing 7 Million Subscribers in Just 2 Years
The Walt Disney Company has been losing millions of subscribers for its cable channels, according to a report from CNN Money. ESPN, its most popular channel, in particular, has lost seven million subscribers in just two years.
Mortgage Rate Eases Slightly, Hasn't Surged Above 4 Percent Since July 23
Freddie Mac said in a press release that their Primary Mortgage Market Survey show mortgage rates have slightly declined leading up to the Thanksgiving holiday. The rates, though, have yet to rise above four percent since July 23, 2015.
U.S. New Home Sales Rebound in October
The U.S. Consensus Bureau has said in a news release that new single-family house sales in October have risen by 10.7 percent from September’s numbers.
Amgen Files for U.S. Approval of Biosimilar Candidate to Himura, First Biosimilar Application of Company
Amgen Inc. has announced in a press release the submission of a Biologics License Application to the U.S. Food and Drug Administration (FDA) for ABP 501, a biosimilar candidate to Humira, or adalimumab, an anti-TNF-α monoclonal antibody. The application is Amgen’s first Biologics License Application submitted using the 351 (k) biosimilar pathway.
PetroChina to Sell Stake at Trans-Asia Gas Pipeline, Seeks to Meet Year-End Profit Target
PetroChina Co., a Chinese state-controlled oil company, is planning to sell its stake in Trans-Asia Gas Pipeline Co. for as much as 15.5 billion yuan or $2.4 billion, according to a report from Bloomberg. The sale is due to the biggest oil and gas producer in China seeking to meet its year-end profit targets and focus on exploration as energy prices continue to slump.
FTC Approves NXP's Acquisition of Freescale, Requires NXP to Divest Radio Frequency Power Assets
The Federal Trade Commission (FTC) has approved the NXP Semiconductor N.V.’s proposed acquisition of Freescale Semiconductor Ltd. for $11.8 billion, according to a press release issued by the FTC. The approval, though, comes with a condition that NXP will divest its radio frequency power assets.
Owner of New Hampshire Waterpark Leaves Slide Tower, Fails to Find Investors
Kevin Dumont, the owner of a water park in New Hampshire, has decided to leave the slide tower after 17 days of chaining himself to the tower, according to a report from ABC News. Dumont ended his quest due to failing health and the lack of a financial investor.
Shire Prepares New Bid for Baxalta, Will Create One of the World's Leading Specialist in Rare Disease if Bid Succeeds
Shire Plc, a company that develops and delivers innovative medicines for patients with rare disease, is preparing to make a new takeover offer to Baxalta, Inc., a source with direct knowledge of the matter told Reuters. The acquisition, if successful, will create one of the world’s leading specialists in rare disease.
Most Read
